177Lu-奥曲肽预注射方案对GOT1肿瘤转录效应的影响
该研究对荷GOT1人小肠神经内分泌肿瘤的裸鼠进行RNA微阵列分析,比较5 MBq预注射后24小时再注射10 MBq的177Lu-奥曲肽方案与未治疗组的转录差异。结果显示预注射方案引起两个阶段的通路调控,早期诱导细胞周期阻滞和凋亡通路,晚期下调促增殖基因,并涉及PI3K/AKT信号和未折叠蛋白反应。
要点
- 预注射方案在早期激活细胞周期阻滞和内外源性凋亡通路。
- 晚期出现促增殖基因下调和PI3K/AKT信号及未折叠蛋白反应相关改变。
- 预注射方案较常规单药治疗诱导更强的细胞应激反应。
核心结论
- 预注射方案较常规177Lu-奥曲肽单药治疗诱导更显著的细胞应激反应,更深度启动细胞周期阻滞和凋亡,并影响PI3K/AKT信号和未折叠蛋白反应。
研究设计与样本
- 研究对荷GOT1人小肠神经内分泌肿瘤的BALB/c裸鼠进行RNA微阵列分析,比较预注射方案治疗组与未治疗组的转录差异。
主要发现
- 预注射方案组肿瘤转录分析显示两个阶段的通路调控(至1周和约1个月),与单药治疗后的细胞反应明显不同。
- 治疗开始后早期时间点发现细胞周期阻滞和凋亡通路(内源性和外源性)诱导。
- 晚期时间点发现促增殖基因下调。
关键数值与推荐
- 差异调控转录本定义为变化≥1.5倍且校正p值<0.01。
- 预注射方案为5 MBq 177Lu-奥曲肽预注射后24小时再注射10 MBq,给药活度选择为非治愈性。
- 在末次注射后1、3、7和41天取材进行RNA微阵列分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: 177Lu-octreotate is used for therapy of somatostatin receptor expressing neuroendocrine tumors with promising results, although complete tumor remission is rarely seen. Previous studies on nude mice bearing the human small intestine neuroendocrine tumor, GOT1, have shown that a priming injection of 177Lu-octreotate 24 h before the main injection of 177Lu-octreotate resulted in higher 177Lu concentration in tumor, resulting in increased absorbed dose, volume reduction, and time to regrowth. To our knowledge, the cellular effects of a priming treatment schedule have not yet been studied. The aim of this study was to identify transcriptional changes contributing to the enhanced therapeutic response of GOT1 tumors in nude mice to 177Lu-octreotate therapy with priming, compared with non-curative monotherapy. RESULTS: RNA microarray analysis was performed on tumor samples from GOT1-bearing BALB/c nude mice treated with a 5 MBq priming injection of 177Lu-octreotate followed by a second injection of 10 MBq of 177Lu-octreotate after 24 h and killed after 1, 3, 7, and 41 days after the last injection. Administered activity amounts were chosen to be non-curative, in order to facilitate the study of tumor regression and regrowth. Differentially regulated transcripts (RNA samples from treated vs. untreated animals) were identified (change ≥ 1.5-fold; adjusted p value < 0.01) using Nexus Expression 3.0. Analysis of the biological effects of transcriptional regulation was performed using the Gene Ontology database and Ingenuity Pathway Analysis. Transcriptional analysis of the tumors revealed two stages of pathway regulation for the priming schedule (up to 1 week and around 1 month) which differed distinctly from cellular responses observed after monotherapy. Induction of cell cycle arrest and apoptotic pathways (intrinsic and extrinsic) was found at early time points after treatment start, while downregulation of pro-proliferative genes were found at a late time point. CONCLUSIONS: The present study indicates increased cellular stress responses in the tumors treated with a priming treatment schedule compared with those seen after conventional 177Lu-octreotate monotherapy, resulting in a more profound initiation of cell cycle arrest followed by apoptosis, as well as effects on PI3K/AKT-signaling and unfolded protein response.
引用
- Spetz J, Langen B, Rudqvist NP, et al. Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice. EJNMMI Res. 2019. PMID: 30895393. doi:10.1186/s13550-019-0500-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。